艾尔建在成都通关首单医疗产品，超亿元乔雅登和酷塑耗材直达蓉城

发布时间：2019-04-16

“经过蓉欧铁路而来的这批艾尔建产品，从爱尔兰的工厂生产出来以后，渡过了英吉利海峡来到了荷兰，然后一路横穿了整个欧洲、中亚，进入我们中国的阿拉山口，最终到达成都。它带着欧洲和中亚的文化气息，是一个具有历史意义的产品。我非常高兴，作为一家全球领先的医药公司，能够充分利用成都‘一带一路’里面蓉欧铁路的物流优势，帮助我们更好地服务整个西南市场。”

——艾尔建全球副总裁兼中国区总裁，王炜

中国成都，2019年4月15日——今天，随着艾尔建公司在成都通关的医疗产品经过成都市政府相关领导之手移交给公司执行副总裁兼国际部总裁Marc Princen，成都国际生物医药供应链服务中心的首单医疗产品通关工作正式完成，由此该中心也正式揭牌运营。

艾尔建公司执行副总裁兼国际部总裁Marc Princen致辞

这是成都首次通过蓉欧铁路运送医疗产品。此次通过中欧铁路以及空运，艾尔建从欧洲将货值超过1亿元的医疗产品运送到成都并在成都通关。这批产品包括冷冻减脂仪酷塑®储存卡等耗材和注射用交联透明质酸钠凝胶乔雅登®。其中酷塑耗材3月1日从爱尔兰出发，历时21天抵达成都，包括卡车运输5天和铁路行程16天。海关流程则仅用3天。

成都全球生物医药供应链服务中心首单医疗产品通关仪式

艾尔建全球副总裁兼中国区总裁王炜表示，在成都通关首单医疗产品，既支持了政府“一带一路”的西部发展战略，又检验了西部地区的物流效率，选择在成都通关，是因为成都在交通上辐射西南部，覆盖的市场范围广。

成都全球生物医药供应链服务中心揭牌暨首单医疗产品通关仪式现场

艾尔建中国商务部门相关负责人指出，成都作为空港和铁路运输港口，为首单通关所做的准备工作充分通过此次通关已经积累一定经验，将来随着通关经验不断增加、数据积累越来越丰富，成都的通关服务会越来越成熟。

成都生物医药供应链背景资料

作为国家布局的重要生物产业基地，成都具有发展生物产业的多重优势，正以成都天府国际生物城为重要载体，全力打造产业发展要素完善、具有国际竞争力和区域带动力的生物产业生态圈。

艾尔建公司医疗产品在成都通关移交仪式

成都天府国际生物城相关负责人表示，成都将打造聚焦生物医药产业的通关服务平台，集聚一批供应链物流企业，共建西部最大的医药进出口商品供应链服务（交易）中心。

目前，从“一带一路”沿线城市看，荷兰鹿特丹、新加坡、香港、上海、广州，都是生物医药供应链枢纽城市的典型案例，同属西部的重庆也正在生物医药供应链领域积极探索；从全国生物医药供应链核心枢纽城市来看则首推上海，上海的生物医药进出口占全国半壁江山，并集聚了一批跨国药企供应链中心、国家级第三方生物医药供应链基地和第三方生物医药供应链服务企业。

“The products that came through the Chengdu-European Railway has passed a long way, starting from Ireland in the west of Europe, crossing the English Channel to the Netherlands, then traveling through Europeand Central Asia, finally reaching Chengdu. This batch of products is a historic product as it has touched the different cultural atmosphere of Europe and Central Asia. I am very glad that as a global leading pharmaceutical company, we can contribute to the “Belt and Road Initiative” and make full use of the logistics advantage of Chengdu-Europe railway to better serve the whole southwest China market.”

——White Wang, VP of Allergan and President of Allergan China

Chengdu, China, April 15, 2019 – Today Allergan celebrated the first customs clearance of its products JUVEDERM® and CoolSculpting® consumables as part of the opening of the Chengdu Biomedical Supply Chain Center in Chengdu City.

Marc Princen, Executive VP of Allergan and President of International Commercial，delivered a speech at the ceremony

This is the first time that medical products were delivered directly to Chengdu via the Government’s new “Belt and Road Initiative.” The product was delivered to Allergan representatives, including Marc Princen, Executive VP of Allergan and President of International Commercial, by the relevant officials of Chengdu Municipal Government, Chengdu International Biomedical Supply Chain Service Center at a formal ceremony to open the Center.

First Custom Clearence Order of Medical Products through Chengdu International Biomedical Supply Chain Service Center

Allergan utilized the Chengdu-Europe Express and air freight to ship more than 100-million-yuan worth of pharmaceutical product from Europe to Chengdu where they officially cleared customs. The shipment includes consumables for freezing and fat-reducing CoolSculpting® equipment, and JUVÉDERM® hyaluronic acid for medical aesthetics injection. The products left the European Union on March 1st and arrived in Chengdu in 21 days, including 5 days by truck and 16 days by train. The customs procedure only took three days to complete.

Opening Ceremony of Chengdu Global Biomedical Supply Chain Service Center and First Custom Clearence Order of Medical Products

White Wang, VP of Allergan and President of Allergan China said, “The customs clearance of our first shipment in Chengdu not only proactively responded to the Chinese and Chengdu Government’s new Belt and Road Initiative, but also examined the efficiency of logistics in the western region of China. We chose Chengdu because of its transportation connection to the southwestern provinces and cities in China, covering numerous markets in a vast area, as well as the province’s focus on becoming China’s 'capital of medical aesthetics.' ”

Background information of Chengdu Biomedical Supply Chain

As an important bio-industrial base in the Country’s national strategy, Chengdu has multiple advantages in developing bio-industry development. Utilizing Chengdu Tianfu International Bio-town as an important carrier, the municipal government is striving to build a bio-industrial ecosystem with optimal industrial development factors, international competitiveness and regional driving force.

The Handover Ceremony of Medical Products

According to officials of from the Chengdu Tianfu International Bio-town, Chengdu will create a customs clearance service platform focusing on the biopharmaceutical industry, gather a number of supply chain logistics enterprises, and build the largest supply chain service (trading) center for import and export of pharmaceutical commodities in the western region of China.

Looking at the cities involved in the Belt and Road Initiative, Holland, Rotterdam, Singapore, Hong Kong, Shanghai and Guangzhou, are all classic cases of the hub city of biopharmaceutical supply chain. Chongqing, like Chengdu in the western region, is also actively exploring in the field of biopharmaceutical supply chain. Shanghai still ranks number one among all the hub cities in China as it comes to the biopharmaceutical supply chain. The import and export of biomedicine in Shanghai account for half of the country's total amount, owing largely to the gathering of multinational pharmaceutical supply chain centers, national third-party biomedicine supply chain bases and third-party biomedicine supply chain service enterprises.

信息来源：艾尔建官方

联系方式

地址：中国（上海）自由贸易试验区外高桥美约路222号五楼501室

邮编：200131

传真：58661522

电话：58661516

邮箱：mdta@mdta.org.cn

艾尔建在成都通关首单医疗产品，超亿元乔雅登和酷塑耗材直达蓉城

联系方式

下载专区

相关链接